Today, Traditional Chinese Medicine products supplier, China Health Resource, Inc., announced record-breaking results for their 3rd Quarter ending September 2011. CHRI reported a 219% increase in revenues, to $9.3 million, and a 141% increase in net income, to $1.8 million. China Health Resource also noted that the net earnings performance in the first three quarters has already exceeded the net profit for the entire year of 2010 by 61%.
CHRI has maintained its profitability with a gross profit margin for the first three quarters of 2011 of 30% and net profit margin of 20%, compared to 33% gross margin and 17% net profit margin for the first three quarters of 2010.
Jiayin Wang, CHRI’s Chairman and CEO, remarked, “CHRI sustained its accelerated growth rate and achieved excellent results in the third quarter this year. Orders in the quarter were up more than double comparing to the same period of last year, while net margin increased from 17% to 20%. This order strength is attributed primarily by the newly introduced products including Rhizoma Gastrodiae or “TianMa” (Gastrodiae) in addition to ongoing order of DAR which transforms into strong excellent performance and improved product margins.”
He added, “A couple reasons contributed to the strong performance in net earnings for the first nine months of 2011. First, there has been an increase in revenue from a higher volume of sales of raw Dahurian Angelica Root (DAR) and Gastrodiae. Demand for these products has been increasing. Furthermore, our brand and franchise is more recognizable and reputable within the industry. Stronger business relationship has been built up with our current and potential customers. We will continue putting all our effort into our future operation and expect to keep the growth pace in sales and earnings.”
Commenting on the future of China Health Resource and the industry as a whole, Mr. Wang commented, “The industry of TCM in China is growing considerably compared to other segments of the healthcare industry and CHRI provides a much needed standard of quality” said Mr. Wang. “The company has now reached an important milestone as a Dragonhead Enterprise with a valuable franchise to provide the foundation for future growth. We expect Gastrodiae (“TianMa”) to be a major contributor to our top and bottom line and we plan to continue to develop other superior products. Our Dragonhead Enterprise status gives us high recognition as a quality company committed to the highest of standards. We believe our GAP standard and committed to quality standard separate us from competitors and our shareholders can depend on our commitment to building a quality company with on-going growth potential.”
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment